Possible Schmallenberg vaccine confirmed
After renewed calls from the farming industry the Veterinary Medicines Directive (VMD) has released information regarding a possible vaccine for Schmallenberg.
The directorate has taken the unusual step of sharing information regarding the MSD's application for its 'Bovilis SBV' vaccine. Usually the directorate is unable to comment on any applications it has received, or their current status, for reasons of commercial confidentiality. However in light of the media interest surrounding the possible vaccine, MSD has allowed the VMD to release certain information.
The VMD has confirmed it received an application for a provisional marketing authorisation at the end of August 2012. The application was then completed and validated in mid September 2012 following the provision of further data.
According to the directorate the initial assessment was completed, and further enquiries were sent to the company in question towards the end of November 2012. After receiving a response at the end of January 2013, the VMD are now assessing this information.
A VMD spokesman said: "Despite the good progress, at this stage it is not possible to provide an indication of when the vaccine may be authorised.
"The VMD recognises the impact on individual animals and farmers a disease such as Schmallenberg can have.
"The VMD will operate timelines for the remaining stages of consideration of the application mindful of this while ensuring, through our rigorous scientific assessment process, that proper care is taken to ensure that any vaccine is safe for the relevant livestock."
BSAVA is to partner with BVA Live (11-12 June 2026) to champion clinical research.
